RYTMMEDIUM SIGNALFINANCIAL10-K

RYTM shows improving operational performance with reduced losses and stronger equity position, despite declining cash reserves and increased debt servicing costs.

The company demonstrated meaningful progress with operating losses improving 28% and cumulative product sales nearly doubling from $227.6M to $422.5M, indicating growing commercial traction. However, the 39% decline in cash to $54.3M combined with 167% increase in interest expense suggests potential liquidity pressures that warrant monitoring.

Comparing 2026-02-26 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

RYTM's financials reflect a company in operational transition, with significantly improved loss metrics (operating income improved 28% to -$192M) and a dramatic 540% increase in stockholders' equity to $139.1M suggesting successful equity financing. However, the substantial decline in cash reserves to $54.3M (-39%) paired with surging interest expenses (+167%) and higher SG&A costs (+35%) indicates increased cash burn from debt servicing and commercial expansion, partially offset by reduced R&D spending (-30%). The overall picture suggests improving core operations but emerging financing pressures that require careful cash management.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+540%
$21.7M$139.1M

Equity base grew 540% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Interest Expense
P&L
+167.1%
$5.2M$13.9M

Interest expense surged 167.1% — significant debt increase or rising rates materially impacting earnings.

Accounts Receivable
Balance Sheet
+40.9%
$18.5M$26.1M

Receivables surged 40.9% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Cash & Equivalents
Balance Sheet
-39.1%
$89.1M$54.3M

Cash declined 39.1% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Inventory
Balance Sheet
+37.4%
$18.7M$25.8M

Inventory surged 37.4% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

SG&A Expense
P&L
+35.1%
$144.3M$194.9M

SG&A up 35.1% — significant increase in sales or administrative costs, monitor impact on operating leverage.

R&D Expense
P&L
-29.7%
$238.0M$167.3M

R&D spending cut 29.7% — could signal cost discipline or concerning reduction in innovation investment.

Operating Income
P&L
+27.7%
-$265.5M-$192.0M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Current Assets
Balance Sheet
+24.8%
$374.2M$466.9M

Current assets grew 24.8% — improving short-term liquidity or inventory/receivables build.

Net Income
P&L
+24.6%
-$260.6M-$196.5M

Net income grew 24.6% — bottom-line growth signals improving overall business health.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-28
ADDED
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $ 3.8 billion, based on the closing price of the registrant s Common Stock on June 30, 2025, the last business day of the registrant s most recently completed second fiscal quarter.
There were 68,285,039 shares of the registrant's Common Stock outstanding as of February 24, 2026.
SUMMARY RISK FACTORS Our business is subject to numerous risks and uncertainties, including those described in Part I, Item 1A.
To date, we have generated approximately $422.5 million from product sales.
We have incurred significant operating losses 3 Table of Conten ts since our inception, anticipate that we will incur continued losses for the foreseeable future and may never achieve profitability.
+7 more — sign up free →
REMOVED
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $ 2.4 billion, based on the closing price of the registrant s Common Stock on June 28, 2024, the last business day of the registrant s most recently completed second fiscal quarter.
There were 63,223,727 shares of the registrant's Common Stock outstanding as of February 24, 2025.
Our actual results may differ significantly from the results discussed in the forward-looking statements.
To date, we have generated approximately $227.6 million from product sales.
We have incurred significant operating losses since our inception, anticipate that we will incur continued losses for the foreseeable future and may never achieve profitability.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →